dc.contributor.author |
Taran, O. |
en |
dc.contributor.author |
Konkov, D. |
en |
dc.contributor.author |
Yaremchuk, L. |
en |
dc.contributor.author |
Lobastova, T. |
en |
dc.contributor.author |
Zhuk, S. |
en |
dc.date.accessioned |
2024-10-14T09:34:11Z |
en |
dc.date.available |
2024-10-14T09:34:11Z |
en |
dc.date.issued |
2024 |
|
dc.identifier.citation |
Taran. O. The effective preventive management for nausea and vomiting in pregnancy and hyperemesis gravidarum [Електронний ресурс] : poster review / O. Taran, D. Konkov, L. Yaremchuk [et al.] // XXIX Europian congress of perinatal medicine, 11-13 sep. 2024, Vienna. – Електрон. текст. дані. – Режим доступу: https://europerinatal.eu/congresses/ecpm-2024/ DOI: 10.13140/RG.2.2.23086.52802 |
en |
dc.identifier.uri |
https://dspace.vnmu.edu.ua/123456789/6614 |
en |
dc.description.abstract |
Nausea and Vomiting in Pregnancy (NVP) and Hyperemesis Gravidarum (HG) are prevalent yet frequently overlooked conditions during pregnancy. They impact 70-80% of pregnant women to varying degrees,
with symptoms often extending beyond the first trimester. NVP affects up to 90% of pregnant women and is one of the most common indications for hospital admission among pregnant women, with typical stays of between three and four days.
In a population based pregnancy cohort using general practice records prevalence of clinically recorded NVP/HG was 9.1%: 2.1% had hospital admissions, 3.4% were treated with antiemetics in primary care only, and 3.6% had only recorded diagnoses. |
en |
dc.language.iso |
en |
en |
dc.subject |
nausea and vomiting in pregnancy |
en |
dc.subject |
hyperemesis gravidarum |
en |
dc.subject |
psychological support |
en |
dc.subject |
diet |
en |
dc.subject |
acupuncture/acupressure |
en |
dc.subject |
ginger |
en |
dc.subject |
pyridoxine |
en |
dc.title |
The effective preventive management for nausea and vomiting in pregnancy and hyperemesis gravidarum |
en |
dc.type |
Presentation |
en |